Literature DB >> 7749123

Immune responses by cord blood cells.

M G Roncarolo1, M Bigler, E Ciuti, S Martino, P A Tovo.   

Abstract

In the present study, the biological properties of cord blood cells were investigated. Cord blood mononuclear cells and T cells responded normally to activation by alloantigens in primary mixed leukocyte reactions (MLRs), indicating that cord blood T cells can be normally activated via their TcR and have normal proliferative capacities. In addition, they expressed normal levels of accessory molecules such as CD28 and LFA-1, which contribute to amplify their responses. In contrast, cord blood mononuclear cells, but not cord blood monocytes, had a reduced capacity to stimulate allogeneic cells in primary MLRs. In addition, cord blood monocytes express lower levels of HLA-DR and ICAM-1 compared to adult peripheral blood monocytes. Cord blood mononuclear cells were also impaired in their capacity to generate allogeneic cytotoxic activity in primary mixed leukocyte cultures (MLCs). In contrast, cord blood B cells were similar to adult B cells in their capacity to switch to immunoglobulin E producing cells when incubated with interleukin-4 (IL-4) and anti-CD40 monoclonal antibody. We also demonstrated that IL-2, IL-6, and tumor necrosis factor-alpha (TNF-alpha) production by activated cord blood mononuclear cells was comparable to that observed with peripheral blood mononuclear cells isolated from normal adult donors. In contrast, interferon-gamma (IFN-gamma) was significantly decreased, whereas IL-4 and IL-5 were absent. Granulocyte-macrophage colony-stimulating factor (GM-CSF) levels were in general higher in the supernatants of cord blood cells. Thus, cord blood immune responses differ from those of peripheral blood at several levels. Whether these differences account for a reduced capacity of transplanted cord blood cells to modulate graft vs. host disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7749123

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  12 in total

1.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.

Authors:  David H Canaday; Soma Chakravarti; Tarun Srivastava; Daniel J Tisch; Vinay K Cheruvu; Jamie Smialek; Clifford V Harding; Lakshmi Ramachandra
Journal:  Cell Immunol       Date:  2007-02-26       Impact factor: 4.868

3.  An animal model for chorioamnionitis at term.

Authors:  Valeria Dell'Ovo; Jason Rosenzweig; Irina Burd; Nana Merabova; Nune Darbinian; Laura Goetzl
Journal:  Am J Obstet Gynecol       Date:  2015-05-12       Impact factor: 8.661

4.  In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults.

Authors:  I Malhotra; J Ouma; A Wamachi; J Kioko; P Mungai; A Omollo; L Elson; D Koech; J W Kazura; C L King
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells.

Authors:  Y Hirose; H Kiyoi; K Itoh; K Kato; H Saito; T Naoe
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 6.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

7.  Low CD3+CD28-induced interleukin-2 production correlates with decreased reactive oxygen intermediate formation in neonatal T cells.

Authors:  S Kilpinen; M Hurme
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

8.  Bone Fracture Healing with Umbilico-Placental Mononuclear Cells: A Controlled Animal Study.

Authors:  Onur Polat; Gurur Polat; Sercin Karahuseyinoglu; Nüket Yörür Kutlay; Arzu Gül Tasci; Esra Erdemli; Ajlan Tukun; Mustafa Cihat Avunduk; Sükrü Küplülü; Mehmet Demirtas
Journal:  Eur J Trauma Emerg Surg       Date:  2009-09-11       Impact factor: 3.693

9.  Dendritic cells in cord blood transplantation: a review.

Authors:  Marta Isabel Pereira; Artur Paiva
Journal:  Stem Cells Int       Date:  2011-06-16       Impact factor: 5.443

Review 10.  Insights and hopes in umbilical cord blood stem cell transplantations.

Authors:  Somayeh Shahrokhi; Farid Menaa; Kamran Alimoghaddam; Colin McGuckin; Massoumeh Ebtekar
Journal:  J Biomed Biotechnol       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.